AMRX
Amneal Pharmaceuticals Stock Analysis
AI Rating
- Quality3/10
- Growth↑ 8/10
- Value↑ 6/10
AMRX Growth
- Revenue Y/Y↑ 8.05%
- EPS Y/Y↑ 160.53%
- FCF Y/Y↓ 3.61%
AMRX Profitability
- Gross margin ↑ 36.90%
- EPS margin↓ 2.40%
- ROIC 5Y↓ 4.73%
AMRX Risk
- Debt / Equity↑ 999.0
- Debt / FCF↑ 9.8
- Interest coverage↓ 1.4
Amneal Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.